Live Breaking News & Updates on Active Ingredients

Stay updated with breaking news from Active ingredients. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by Assetmark Inc.

Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by Assetmark Inc.
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Blue Trust Inc , Exchange Commission , Reddy Laboratories Company Profile , Reddy Laboratories Limited , Assetmark Inc , Reddy Laboratories , Lindbrook Capital , Laboratories Limited , Free Report , Global Generics , Pharmaceutical Services , Active Ingredients , Visit Holdingschannel , Laboratories Daily ,

Dr. Reddy's Laboratories (NYSE:RDY) Downgraded by StockNews.com

StockNews.com downgraded shares of Dr. Reddy’s Laboratories (NYSE:RDY – Free Report) from a strong-buy rating to a buy rating in a report published on Thursday. Separately, Barclays lifted their price objective on shares of Dr. Reddy’s Laboratories from $80.00 to $81.00 and gave the company an overweight rating in a research note on Wednesday, May […] ....

New Zealand General , New Zealand , Wellington Management Group , Sequoia Financial Advisors , Fisher Asset Management , Reddy Laboratories , Allspring Global Investments Holdings , Free Report , Global Investments Holdings , Financial Advisors , Management Group , Asset Management , Nordea Investment Management , Investment Management , Get Free Report , Laboratories Limited , Global Generics , Pharmaceutical Services , Active Ingredients , Laboratories Daily ,

Dr. Reddy's Laboratories (NYSE:RDY) Cut to Buy at StockNews.com

StockNews.com cut shares of Dr. Reddy’s Laboratories (NYSE:RDY – Free Report) from a strong-buy rating to a buy rating in a research report report published on Thursday morning. Separately, Barclays lifted their price target on shares of Dr. Reddy’s Laboratories from $80.00 to $81.00 and gave the company an overweight rating in a research note […] ....

Healthcare Of Ontario Pension Plan Trust Fund , Mission Capital , Reddy Laboratories , Bessemer Group Inc , Reddy Laboratories Company Profile , Promethos Capital , Free Report , Street Group , Ontario Pension Plan Trust Fund , Get Free Report , Laboratories Limited , Global Generics , Pharmaceutical Services , Active Ingredients , Laboratories Daily ,